Over the past 12 months, 0 insiders at Checkmate Pharmaceuticals, Inc. filed 0 open-market SEC Form 4 transactions on CMPI: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| May 16, 22 | Corey S GoodmanTenPercentOwner | SELL | 95.8K | $10.45 | $1.0M |
| May 13, 22 | Corey S GoodmanTenPercentOwner | SELL | 35.9K | $10.45 | $375K |
| May 12, 22 | Venbio Global Strategic Fund II L.p.TenPercentOwner | SELL | 124.5K | $10.39 | $1.3M |
| May 11, 22 | Venbio Global Strategic Fund II L.p.TenPercentOwner | SELL | 17.7K | $10.38 | $184K |
| May 10, 22 | Venbio Global Strategic Fund II L.p.TenPercentOwner | SELL | 18.7K | $10.38 | $194K |
| May 9, 22 | Venbio Global Strategic Fund II L.p.TenPercentOwner | SELL | 17.6K | $10.37 | $183K |
| May 6, 22 | Venbio Global Strategic Fund II L.p.TenPercentOwner | SELL | 48.3K | $10.37 | $501K |
| May 5, 22 | Venbio Global Strategic Fund II L.p.TenPercentOwner | SELL | 20.7K | $10.37 | $215K |
| May 4, 22 | Venbio Global Strategic Gp Ii, Ltd.TenPercentOwner | SELL | 37.5K | $10.37 | $389K |
| May 3, 22 | Venbio Global Strategic Gp Ii, Ltd.TenPercentOwner | SELL | 79.5K | $10.37 | $824K |
| May 2, 22 | Venbio Global Strategic Gp Ii, Ltd.TenPercentOwner | SELL | 153.7K | $10.38 | $1.6M |
| Apr 29, 22 | Venbio Global Strategic Fund II L.p.TenPercentOwner | SELL | 69.2K | $10.38 | $719K |
| Apr 28, 22 | Venbio Global Strategic Fund II L.p.TenPercentOwner | SELL | 73.4K | $10.38 | $762K |
| Apr 27, 22 | Venbio Global Strategic Fund II L.p.TenPercentOwner | SELL | 47.4K | $10.38 | $492K |
| Apr 26, 22 | Venbio Global Strategic Gp Ii, L.p.TenPercentOwner | SELL | 64.7K | $10.38 | $671K |
| Apr 25, 22 | Venbio Global Strategic Gp Ii, L.p.TenPercentOwner | SELL | 27.7K | $10.39 | $287K |
| Apr 22, 22 | Venbio Global Strategic Gp Ii, L.p.TenPercentOwner | SELL | 37.4K | $10.39 | $389K |
| Apr 21, 22 | Venbio Global Strategic Gp Ii, Ltd.TenPercentOwner | SELL | 62.2K | $10.38 | $646K |
| Apr 20, 22 | Venbio Global Strategic Gp Ii, Ltd.TenPercentOwner | SELL | 85.6K | $10.39 | $889K |
| Apr 19, 22 | Venbio Global Strategic Gp Ii, Ltd.TenPercentOwner | SELL | 399.9K | $10.42 | $4.2M |
| Feb 25, 22 | Novo Holdings A/sTenPercentOwner | SELL | 300 | $2.70 | $810 |
| Feb 24, 22 | Novo Holdings A/sTenPercentOwner | SELL | 6.0K | $2.83 | $17K |
| Feb 23, 22 | Novo Holdings A/sTenPercentOwner | SELL | 1.8K | $2.90 | $5K |
Over the past 12 months, insiders at Checkmate Pharmaceuticals, Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on CMPI, which makes them mixed over the period. The most recent Form 4 was filed on .
0 different insiders at Checkmate Pharmaceuticals, Inc. filed open-market SEC Form 4 transactions on CMPI over the last 12 months.
InsiderTape plots every CMPI insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Checkmate Pharmaceuticals, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →